Page 35 - Ischemic Stroke News Today

According to a new American Heart Association scientific statement, people with dementia or a pre-existing disability who receive timely and appropriate treatment for ischemic stroke (caused by a blood clot) may avoid additional disability and the subsequent health and financial impacts of stroke.

Antidopaminergic antiemetics (ADAs) used to relieve nausea and vomiting, including that induced by chemotherapy or radiotherapy, have been associated with an increased risk of ischemic stroke.

The first year of the COVID-19 pandemic saw fewer hospital visits for stroke, fewer stroke therapies, more treatment delays and a higher risk of in-hospital deaths in the subsequent COVID-19 waves, according to an Alberta study published in CMAJ.

Antidopaminergic antiemetics (ADAs) that are widely used to ease nausea and vomiting are associated with a higher risk of ischemic stroke.

A new study suggests left atrial myopathy could signal an increased risk of developing dementia and treating this condition could potentially be a new approach to prevention.

An advisory from the American Academy of Neurology on preventing recurrent stroke in symptomatic intracranial atherosclerosis recommends antiplatelets and statins but advises against stenting.

A new study shows higher risk for further cardiovascular events and strokes in patients with a recent stroke of atherothrombotic origin and raised triglyceride levels, even accounting for statin use.

Although dual antiplatelet therapy using cilostazol is associated with a lower risk of recurrent stroke in men, it has no significant benefit for women, a sub-analysis of CSPS.com results suggests.

Eighteen months after approval of the Watchman FLX device, new registry data support its safety outside of a trial setting.

In a population-based cohort study, Alis Heshmatollah and colleagues investigate the associations between blood pressure variability and risk of stroke among adults in the Netherlands.